December 12, 2020

FDA GRANTS PFIZER EUA FOR COVID-19 VACCINE

The Food and Drug Administration (FDA) issued its first emergency use authorization for the COVID-19 vaccine developed by Pfizer Inc. and BioNTech Friday evening, a move that was warmly greeted by the healthcare industry as the U.S. and nations around the world continue to face unprecedented challenges caused by the pandemic.

The authorization allows for the emergency use of the vaccine in individuals that are 16 years of age or older and Pfizer stated that the company expects to file for possible full regulatory approval next year. Read more.